Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 7.61% is 23% below its 5-year average of 9.83%, near the high end of its 5-year range (-5.72%–10.51%).
5.20% below its 12-month average of 8.03%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 1.86%.
GROSS MARGIN
7.61%
GROSS MARGIN AVG TTM
8.03%
GROSS MARGIN AVG 3Y
9.78%
GROSS MARGIN AVG 5Y
9.83%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-5.20%
CURRENT VS 3Y AVG
-22.21%
CURRENT VS 5Y AVG
-22.56%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
41.38%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-81.61%
vs the sector median at left
Privia Health Group, Inc.
Market Cap
$2.56B
Gross Margin
7.61%
TTM Avg
8.03%
3Y Avg
9.78%
5Y Avg
9.83%
Market Cap
$2.60B
Gross Margin
84.05%
TTM Avg
-197.31%
3Y Avg
-176.53%
5Y Avg
-71811.06%
Market Cap
$2.60B
Gross Margin
92.15%
TTM Avg
99.87%
3Y Avg
99.94%
5Y Avg
66.62%
Market Cap
$2.61B
Gross Margin
46.93%
TTM Avg
47.02%
3Y Avg
48.36%
5Y Avg
47.58%
Market Cap
$2.49B
Gross Margin
88.07%
TTM Avg
88.93%
3Y Avg
87.75%
5Y Avg
88.00%
Market Cap
$2.66B
Gross Margin
31.95%
TTM Avg
33.09%
3Y Avg
31.97%
5Y Avg
31.83%
Market Cap
$2.43B
Gross Margin
-61.96%
TTM Avg
-19.42%
3Y Avg
-14.39%
5Y Avg
23.74%
Market Cap
$2.70B
Gross Margin
17.61%
TTM Avg
20.09%
3Y Avg
39.91%
5Y Avg
58.59%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | $2.56B | 7.61% | 8.03% | 9.78% | 9.83% |
| Beam Therapeutics Inc. (BEAM)vs › | $2.60B | 84.05% | -197.31% | -176.53% | -71811.06% |
| NewAmsterdam Pharma Company N.V. (NAMS)vs › | $2.60B | 92.15% | 99.87% | 99.94% | 66.62% |
| Neogen Corporation (NEOG)vs › | $2.61B | 46.93% | 47.02% | 48.36% | 47.58% |
| Supernus Pharmaceuticals, Inc. (SUPN)vs › | $2.49B | 88.07% | 88.93% | 87.75% | 88.00% |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.66B | 31.95% | 33.09% | 31.97% | 31.83% |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.43B | -61.96% | -19.42% | -14.39% | 23.74% |
| Precigen, Inc. (PGEN)vs › | $2.69B | 37.05% | 14.17% | 26.62% | -34.97% |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.70B | 17.61% | 20.09% | 39.91% | 58.59% |
| MBX Biosciences, Inc. Common Stock (MBX)vs › | $2.71B | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
7.6%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 1.86% |
| 2026-03-31 | 9.44% |
| 2025-12-31 | 9.18% |
| 2025-09-30 | 10.51% |
| 2025-06-30 | 9.15% |
| 2025-03-31 | 9.53% |
| 2024-12-31 | 10.41% |
| 2024-09-30 | 10.36% |
| 2024-06-30 | 10.11% |
| 2024-03-31 | 9.84% |
| 2023-12-31 | 8.86% |
| 2023-09-30 | 10.00% |
| 2023-06-30 | 10.02% |
| 2023-03-31 | 10.17% |
| 2022-12-31 | 10.07% |
| 2022-09-30 | 9.88% |
| 2022-06-30 | 10.09% |
| 2022-03-31 | 9.67% |
| 2021-12-31 | 9.04% |
| 2021-09-30 | 10.40% |
| 2021-06-30 | -5.72% |
| 2021-03-31 | 11.95% |
| 2020-12-31 | 10.95% |
| 2020-09-30 | 10.38% |
| 2020-06-30 | 9.50% |
| 2020-03-31 | 9.52% |
